Biotechnology News

October 24, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX) announced today that it will present at the Credit Suisse 21st Annual Healthcare Conference on Wednesday, November 14, at 9:30 a.m. (CT). The live webcast of Baxter’s...

October 24, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock on October 24, 2012. This dividend is payable on February 8, 2013, to all...

October 24, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq: XNPT) announced today financial results for the third quarter and nine months ended September 30, 2012. Revenues for the third quarter were $0.4 million, compared to $0.4 million for...

October 24, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) today announced financial results for the third quarter ended September 30, 2012. Dyax will host a webcast and conference call at 5:00 p.m. (ET) today to review financial results and...

October 24, 2012

MONTREAL--(BUSINESS WIRE)--Clinical studies have shown that an investigational new drug, pomalidomide, has demonstrated overall survival in a clinical trial of myeloma patients who had undergone multiple prior treatments.

October 24, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Nearly half of surveyed companies report coordinating through globally centralized market research groups.

October 24, 2012

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology closed its previously announced $138 million public offering of common stock.

October 24, 2012

NORTH HOLLYWOOD, Calif.--(BUSINESS WIRE)--The IMF says pomalidomide, an investigational drug for multiple myeloma, has demonstrated overall survival even in patients who have undergone multiple previous treatments, as shown in Phase III study

October 24, 2012

DALLAS--(BUSINESS WIRE)--Statewide Clinical Trials Network of TX (CTNeT) Announces Liver Cancer Study Will Launch Organization’s Portfolio of Clinical Trials; study evaluating activity of GenSpera's lead drug candidate G-202

October 24, 2012

NEW YORK--(BUSINESS WIRE)--Andrew B. Roth, a Member of the Health Law Practice of Mintz Levin, will present during an American Health Lawyers Association (AHLA) Graduate Medical Education Bootcamp Webinar on October 25.

October 24, 2012

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. announced today that the European Commission has given conditional marketing authorization for XALKORI® (crizotinib) in the European Union (EU) for the treatment of adults with previously treated anaplastic...

October 24, 2012

BIRMINGHAM, Ala.--(BUSINESS WIRE)--Research presented at the AHA Scientific Sessions 2012 in Los Angeles will highlight the critical role the Atherotech VAP Lipid Panel plays in clinical research and heart disease risk assessment.

October 24, 2012

LOS ANGELES--(BUSINESS WIRE)--Thermo Fisher Scientific sells Laboratory Workstations division to middle market acquisition and operations firm, OpenGate Capital

October 24, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Acusphere, Inc. (ACUSD.PK) today announced that it has submitted the Marketing Authorisation Application (MAA) for its lead product candidate, Imagify™ (Perflubutane Polymer Microspheres) lyophilisate for...

October 24, 2012

LIBERTYVILLE, Ill.--(BUSINESS WIRE)--Valent BioSciences Corporation (VBC) announced it has hired Mike Daily as plant manager for its new state-of-the art biorational production facility in Osage, IA. The $150 million plant is slated to begin...

October 24, 2012

ST. LOUIS--(BUSINESS WIRE)--Mediomics, LLC has been awarded a $997,251 Phase II SBIR contract (HHSN261201200081C) from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services.

October 24, 2012

BERKELEY, Calif.--(BUSINESS WIRE)--DSM, a global leader in biomedical materials sciences, and AxioMed Spine Corporation, an innovator in the field of spinal implant devices, today announced that they have revised and extended an existing...

October 24, 2012

AUSTIN, Texas--(BUSINESS WIRE)--Mirna Therapeutics Inc. (Mirna), development and commercialization of microRNA completion of a $34.5 million Series C financing

October 24, 2012

SAN FRANCISCO--(BUSINESS WIRE)--Sequenta, Inc. today announced it has received Clinical Laboratory Improvement Amendments (CLIA) certification.

October 24, 2012

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) announced today that it will report its third quarter and year-to-date 2012 financial results on Wednesday, November 7, 2012, after the close of financial markets. Following...

October 24, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Cutting Edge Information’s new study finds that one-quarter of Top 20 drug companies have centralized compliance teams.

October 24, 2012

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, announced today the closing of its previously announced underwritten public offering of 9,200,000...

October 24, 2012

MALVERN, Pa.--(BUSINESS WIRE)--Aclaris Therapeutics Inc., a privately held specialty pharmaceutical company dedicated to developing dermatological therapeutics, announced today that it has secured $21 million in Series A financing.

October 24, 2012

NEW YORK--(BUSINESS WIRE)--CIT Group Inc. (NYSE: CIT), a leading provider of financing to small businesses and middle market companies, today announced that it arranged and syndicated a $75 million senior secured credit facility to Dallas-based...

October 24, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--BIND Biosciences to Present at Lazard Capital Markets Healthcare Conference

October 24, 2012

SAN CARLOS, Calif.--(BUSINESS WIRE)--Alvine Pharmaceuticals Presents Celiac Disease Symptom Study Results at ACG Meeting

October 24, 2012

DALLAS--(BUSINESS WIRE)--Pomalidomide, being tested for multiple myeloma, improves overall survival in patients in a clinical trial. Leaders of Tackle Cancer Foundation say there’s hopeful news for patients with myeloma.

October 24, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--GnuBIO unveils the prototype of the first ever benchtop fully integrated DNA sequencing system. This system will be a paradigm shift in healthcare.

October 24, 2012

WHITE PLAINS, N.Y.--(BUSINESS WIRE)--Orgenesis Inc. (ORGS) (“Orgenesis” or the “Company”), a development-stage company with a novel therapeutic technology dedicated to converting a patient’s own liver cells into functioning insulin-producing...

October 24, 2012

PINE BROOK, N.J.--(BUSINESS WIRE)--Ezose Sciences will apply glycan analysis to discovering diagnostic biomarkers of multiple sclerosis.

October 24, 2012

AUSTIN, Texas--(BUSINESS WIRE)--Asuragen to present at Association for Molecular Pathology in the areas of oncology, genetic testing, microRNA and next generation sequencing. Association for Molecular Pathology

October 24, 2012

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Codexis, Inc. (NASDAQ: CDXS), a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals, and pharmaceuticals, today announced it will host a conference call and webcast on...

October 24, 2012

FRAZER, Pa.--(BUSINESS WIRE)--Teva Women’s Health, Inc., a U.S.-based subsidiary of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), today announced the findings from a Phase III pivotal trial of QuartetteTM (levonorgestrel/ethinyl estradiol...

October 24, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC: Alzheimer’s Epidemic Draws $100 Million in Research

October 24, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for accelerated review of ARIAD’s...

October 24, 2012

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Reports Third Quarter 2012 Financial Results

October 24, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that it will release its third quarter 2012 financial results before the market opens on Tuesday, November 6, 2012.

October 24, 2012

SAN DIEGO--(BUSINESS WIRE)--Santarus, Inc. (NASDAQ: SNTS) today announced that it will release third quarter 2012 financial results after market close on Wednesday, November 7, 2012. Santarus management will host an investment-community...

October 24, 2012

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) (Alexion or the Company) today announced financial results for the three and nine months ended September 30, 2012. Alexion reported net product sales of Soliris® (...

October 24, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Positive Results from Phase 2b Study of Ophthotech’s Novel Anti-PDGF Combination Agent Fovista To Be Presented at AAO Retina Subspecialty Day

October 24, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the third quarter ended September 29, 2012. Third Quarter Highlights Adjusted earnings per...

October 24, 2012

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: DiaGenic ASA (OSE:DIAG): The interim report for the third quarter 2012 was approved by the Board of Directors on 23 October 2012. Please find the interim report and presentation attached. Highlights...

October 24, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Precise Biometrics: (STO:PREC) PRECISE BIOMETRICS AB (PUBL), CORPORATE IDENTITY NO. 556545-6596 INTERIM REPORT FOR THE PERIOD JANUARY – SEPTEMBER 2012 · The group’s net sales for the interim period was...

October 24, 2012

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc today reported its third quarter and first nine months 2012 financial results. “The third quarter was an active one for Elan on a number of fronts.” said Mr. Kelly Martin, chief executive officer. “...

October 23, 2012

SINGAPORE & JAKARTA, Indonesia--(BUSINESS WIRE)--Quintiles starts its first global study involving Indonesia, made possible by an exclusive alliance with Prodia Clinical Laboratory as a provider of in-country testing of samples from Indonesia...

October 23, 2012

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cordis Corporation's SAPPHIRE Worldwide Study demonstrates benefit of Carotid Artery Stenting in Symptomatic and Asymptomatic Patients at High Risk of Surgery presented at TCT

October 23, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced financial results for the third quarter of 2012. Third quarter 2012 results: Revenue of $286 million, a 21% increase compared to $235 million in the third quarter of 2011....

October 23, 2012

MURRAY HILL, N.J.--(BUSINESS WIRE)--C. R. Bard, Inc. (NYSE: BCR) today reported 2012 third quarter financial results. Third quarter 2012 net sales were $722.9 million, an increase of 1 percent over the prior-year period on a reported basis....

October 23, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the quarter ended September 30, 2012. Total revenues for the third quarter of 2012 increased 14 percent to $2.43 billion,...